Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Holding in Top 10
Increase
Decrease
Funds Holding
3,022
Funds Holding Change
-6
Funds Holding Growth
-0.2%
Value
$1.05T
Holding in Top 10
1,225
Top 10 Change
-57
Top 10 Growth
-4%
Value Growth
+6%
New
72
Increased
1,310
Reduced
1,457
Closed
47
Capital Inflow
$31.8B
Capital Outflow
$19.7B
Net Capital Flow
+$12.1B
Capital Flow Change
+$8.21B
Calls
$12.8B
Puts
$13.6B
Net Calls
-$736M
Put/Call Ratio
1.06